A male with primary accessory breast carcinoma in an axilla is strongly suspected of having hereditary breast cancer

Eriko Takahashi1, Kaori Terata1, Hiroshi Nanjo2, Koichi Ishiyama3, Yuko Hiroshima2, Ayuko Yamaguchi1, Misako Yatsuyanagi1, Chiaki Kudo1, Akiyuki Wakita1, Shinogu Takashima1, Yusuke Sato1, Kazuhiro Imai1, Satoru Motoyama1, Yoshihiro Minamiya1
1Department of Thoracic Surgery, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan
2Department of Pathology, Akita University Hospital, Akita, Japan
3Department of Diagnostic Radiology, Akita University Hospital, Akita, Japan

Tóm tắt

Abstract

We herein report on a male with primary accessory breast cancer in an axilla. A 75-year-old man first noticed a subcutaneous nodule about 2 cm in diameter in the area of his right axilla. The patient underwent extirpation of the mass in a public hospital. Histological examination revealed invasive breast carcinoma of no special type associated with mucinous carcinoma, invasive micropapillary carcinoma and intraductal components. Immunohistochemical analysis showed that the tumor cells were positive for Gross cystic disease fluid protein (GCDFP)-15, mammaglobin and GATA3. Staining for estrogen receptor (ER) and progesterone receptor (PR) was positive, and human epidermal growth factor receptor 2 (HER2) was negative. The Ki67 labeling index (LI) was 33.6%. Imaging revealed no evidence of a primary tumor in any other organ or in the bilateral mammary gland. We performed radical resection of the right axilla, including the scar, and axillary lymph node dissection. The final pathological examination of the surgical specimen showed normal mammary gland tissue that was not connected to the proper mammary gland, and no residual cancer or metastatic lymph nodes. Based on our clinical and pathological findings, this tumor was diagnosed as breast cancer originating from the accessory mammary gland in the right axilla. After surgery, tamoxifen was administered as adjuvant therapy. Since the surgery, 2 years ago, there has been no evidence of recurrence. Hereditary Breast and Ovarian Cancer syndrome was suspected in this case because the patient was a male with breast cancer, and he had two first-degree relatives with breast cancer. This patient had no BRCA mutations on genetic testing. Nonetheless, in cases of male breast cancer, it is necessary to obtain genetic information due to the possibility of hereditary breast cancer, including cancers associated with BRCA gene mutation.

Từ khóa


Tài liệu tham khảo

Kudo M, Kumamaru H, Isozumi U et al (2020) Annual report of the Japanese Breast Cancer Society registry for 2016. Breast Cancer 27:511–518

Kitamura K, Kuwano H, Kiyomatsu K et al (1995) Mastopathy of the accessory breast in the bilateral axillary regions occurring concurrently with advanced breast cancer. Breast Cancer Res Treat 35:221–222

Nagaoka H, Takahashi T, Sugitani K et al (2014) A case of primary accessory breast cancer in a male (in Japanese with English). Kitakanto Med J 64:165–170

Maki T, Murakami A, Morishita M et al (2015) Right axillary accessory breast cancer. Rinsho Derma 57:1147–1151

Xia W, Cheng J, Zhang H, Yantao LuA (2015) A male patient with Kallmann syndrome and accessory breasts. Radiol Infect Dis 2:141–145

Shin SJ, Sheikh FS, Allenby PA et al (2001) Invasive Secretory (juvenile) carcinoma arising in ectopic breast tissue of axilla. Arch Pathol Lab Med 125:1372–1374

Yerra L, Karnad B, Votaw ML (1997) Primary breast cancer in aberrant breast tissue in the axilla. South Med J 90:661–662

Korde LA, Zujewski JA, Kamin L et al (2010) Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol 28:2114–2122

National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology. Genetic/familial high-risk assessment: breast and ovarian, ver3.2019, p 6. https://www.2.tri-kobe.org/nccn/guideline/gynecological/english/genetic_familial.pdf. Accessed 1 Nov 2020

Sakurai A, Akagi K, Izumi M et al (2017) Genetic diagnosis and genetic counseling. In: Hukumura N (ed) Guidebook for diagnosis and treatment of hereditary breast and ovarian cancer syndrome 2017, 1st edn. Kanehara, Tokyo, pp 75–76

Momozawa Y, Iwasaki Y, Parsons MT et al (2018) Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls. Commun Nat. https://doi.org/10.1038/s41467-018-06581-8